Interpretation and Implementation of International Radiation Protection Standards for Cardiac Pacemakers in the USA
The cardiac pacemaker is the first prosthetic device powered by nuclear energy to achieve practical application in man. Nuclear batteries in pacemakers have the potential of providing significant benefits to patients by extending the operating life of the pacemaker well beyond that which can be achieved by the current generation of pacemakers powered by mercury batteries. Any use of radioactive materials, however, involves an implied risk of genetic or somatic effects through exposure to external radiation, or inhalation or ingestion of the radioactive material. In the case of nuclear pacemakers, the benefits are received by a relatively small group of patients while the general population is placed at some risk.
KeywordsMercury Europe Lithium Transportation Helium
Unable to display preview. Download preview PDF.
- 1.“Radiation Protection, Recommendations of the International Commission on Radiological Protection”, ICRP Publication 9Google Scholar
- 2.“Safety and Radiation Report, Radioisotope Powered Cardiac Pacemaker Program”, NUMEC 3731–23, June 1970, pp. 115–124Google Scholar
- 3.“Statistical Testing of Nuclear Powered Cardiac Pacemakers”, Materials Branch, Directorate of Licensing, U. S. Atomic Energy CommissionGoogle Scholar
- 4.. R.W. McKee et al, “Dose to the Population Estimates for Use of Radioisotope Powered Cardiac Pacemakers”, Battelle Northwest Laboratories, 1858 ( Draft ), September 1974Google Scholar
- 5.“Radiation Protection, Implications of Commission Recommendations that Doses be Kept as Low as Readily Achievable”, Recommendations of the International Commission on Radiological Protection, ICRP Publication 22Google Scholar
- 6.W. Roger, “Testimony in U.S. Atomic Energy Commission Hearing on Effluents from Light Water Power Reactors”, December 5, 1973Google Scholar